Chugai Pharmaceutical Co., Ltd. CHGCY
21.59 USD -0.11 (-0.51%)
Nov 3, 2026, 2:44 PM EST
21.54 Day range 21.70
18.33 52-week range 34.84
- YTD
- -17.81%
- 1 year
- -6.13%
- Market cap
- 71.06B
- EPS (ttm)
- 0.97
- P/E ratio
- 22.26
- YTD return
- -17.81%
- 1-year return
- -6.13%
- Volume
- 8.51K
- Avg volume
- 306.44K
- Open
- 21.70
- Previous close
- 21.70
- Day's range
- 21.54 – 21.70
- 52-week range
- 18.33 – 34.84
2Y -2.19 (-9.21%)
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jul 24, 2026 | Jun 30, 2026 | — | 0.22 | — | — |
| Apr 24, 2026 | Mar 31, 2026 | — | 0.22 | — | — |
| Jan 29, 2026 | Dec 31, 2025 | — | 0.25 | — | — |
| Oct 24, 2025 | Sep 30, 2025 | — | 0.23 | — | — |
| Jul 24, 2025 | Jun 30, 2025 | — | 0.20 | — | — |
News
Chugai Pharmaceutical Co., Ltd. (CHGCY) Q3 2026 Earnings Call Transcript 
Financial Analysis: Chugai Pharmaceutical (OTCMKTS:CHGCY) & Theravance Biopharma (NASDAQ:TBPH) 
Chugai Pharmaceutical (OTCMKTS:CHGCY) Reaches New 52-Week Low – Should You Sell? 
Analyzing Chugai Pharmaceutical (OTCMKTS:CHGCY) & Ascend Wellness (OTCMKTS:AAWH) 
Chugai Pharmaceutical (OTCMKTS:CHGCY) Sees Unusually-High Trading Volume – Here’s What Happened 
Chugai Pharmaceutical (OTCMKTS:CHGCY) Shares Gap Down – Here’s What Happened 
Short Interest in Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (OTCMKTS:CHGCY) Decreases By 54.9% 
Chugai Pharmaceutical Co., Ltd. (CHGCY) Q2 2026 Earnings Call Transcript 
Chugai Pharmaceutical Co., Ltd. (CHGCY) Q1 2026 Earnings Call Transcript 
Chugai Pharmaceutical Co., Ltd. (CHGCY) Q4 2025 Earnings Call Transcript
Your note
Sign in to keep a note on CHGCY — it syncs with the Stock Master app.